Your institution may have access to this item. Find your institution then sign in to continue.
Title
First-in-class approval rate stays steady.
Abstract
The article reports on a study by Janet Woodcock and her colleagues at the U.S. Food and Drug Administration (FDA) which shows the year-to-year drug approval variation triggered by addition-to-class agents.